Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Destra Multi-Alternative FundDMA · Entity 7034 | Assistant Portfolio Manager | April 28, 2022 | April 29, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Destra Multi-Alternative Fund
Report date April 28, 2022 · Filed April 29, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| DMASEC Table I · non-derivative | Direct | Not disclosed |
Reported balance
After 2022-04-28 transaction · row 1
1 source rowRow 1 · 2022-04-28 · Purchase · Acquired 253 · Balance Not disclosed |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2022 Filed Apr 29, 2022 15:04 UTC | Destra Multi-Alternative Fund DMA · Entity 7034 | PurchaseDMA | 253 | $8.24 | $2,084.72 |
DisclosureSEC source: 0001913471-22-000001 · primary_doc.xml · nonDerivative · entry 1 Leeds Zach · CIK 0001913471 · Assistant Portfolio Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.